U.S. flag An official website of the United States government
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Verichem Laboratories, Inc. - 11/07/2016
  1. Warning Letters


Verichem Laboratories, Inc.

Verichem Laboratories, Inc.

United States

Issuing Office:

United States


Department of Health and Human Services logoDepartment of Health and Human Services

Public Health Service
Food and Drug Administration
 New England District Office
One Momvale Avenue, 4th lloor
Stoneham, MA 02180
Phone 781.587.7500
Fax 781.587.7556

November 7, 2016

Anthony J. DiMonte
Verichem Laboratories, Inc.
90 Narragansett Ave.
Providence, RI 02907-3358

Dear: Mr. DiMonte:

The Food and Drug Administration has completed an evaluation of your firm's corrective actions in response to our Warning Letter# 446069, dated February 4, 2015. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

Diane M. Prince
Acting Director, Compliance Branch
New England District

Back to Top